English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Researchers find neurobiological link between age-related hearing loss and cognitive decline
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Deep learning model shows promise in detecting lung nodules on CT scans
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

New research reviews role of plant-based compounds in rheumatoid arthritis therapy
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Sleep deprivation triggers brief sleep-like brain states tied to lapses in attention
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Study finds reduced employment and income among people diagnosed with HIV in Netherlands
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Researchers engineer CAR T cells resistant to tumor suppression for potential use against solid cancers
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Study links grade of precancerous lesions in IBD patients to future colorectal cancer risk
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Study finds no link between ketamine’s psychedelic effects and sobriety outcomes

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones